Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000685037> ?p ?o ?g. }
- W2000685037 endingPage "S44" @default.
- W2000685037 startingPage "S36" @default.
- W2000685037 abstract "New treatment options are urgently needed for patients with relapsed multiple myeloma (MM) who are refractory to thalidomide, lenalidomide, and bortezomib therapy. Pomalidomide, a second-generation immunomodulatory agent, has been shown to exert direct antiproliferative actions on MM cells, effects on the bone-marrow microenvironment, and immunomodulation. In phase I clinical trials, pomalidomide has demonstrated promising response rates in patients with relapsed and/or refractory MM, with manageable toxicity. In phase II trials pomalidomide, 2-4 mg/daily, given continuously or on days 1-21 of a 28-day cycle, in combination with dexamethasone, has been associated with high quality and durable clinical responses in patients who are refractory to lenalidomide, bortezomib, or both. Pomalidomide appears to be well tolerated; hematologic toxicities are the most commonly reported adverse events and peripheral neuropathy is rare. Phase III trials are currently underway to determine the optimal dose and combination regimen of pomalidomide in the treatment of MM." @default.
- W2000685037 created "2016-06-24" @default.
- W2000685037 creator A5043526996 @default.
- W2000685037 creator A5056839401 @default.
- W2000685037 creator A5076611748 @default.
- W2000685037 date "2013-10-01" @default.
- W2000685037 modified "2023-10-16" @default.
- W2000685037 title "Pomalidomide: New immunomodulatory agent with potent antiproliferative effects" @default.
- W2000685037 cites W1966156828 @default.
- W2000685037 cites W1968654086 @default.
- W2000685037 cites W1969648097 @default.
- W2000685037 cites W1970309861 @default.
- W2000685037 cites W1973532909 @default.
- W2000685037 cites W1973888964 @default.
- W2000685037 cites W1975783065 @default.
- W2000685037 cites W1975916512 @default.
- W2000685037 cites W1977081742 @default.
- W2000685037 cites W1992470642 @default.
- W2000685037 cites W1992538067 @default.
- W2000685037 cites W1997952190 @default.
- W2000685037 cites W1999088487 @default.
- W2000685037 cites W2000047150 @default.
- W2000685037 cites W2012959199 @default.
- W2000685037 cites W2021954218 @default.
- W2000685037 cites W2024896486 @default.
- W2000685037 cites W2025656486 @default.
- W2000685037 cites W2046118145 @default.
- W2000685037 cites W2048185240 @default.
- W2000685037 cites W2059873406 @default.
- W2000685037 cites W2065859796 @default.
- W2000685037 cites W2066800926 @default.
- W2000685037 cites W2066936999 @default.
- W2000685037 cites W2094933328 @default.
- W2000685037 cites W2097860477 @default.
- W2000685037 cites W2128903704 @default.
- W2000685037 cites W2131778873 @default.
- W2000685037 cites W2133739087 @default.
- W2000685037 cites W2133986577 @default.
- W2000685037 cites W2135404380 @default.
- W2000685037 cites W2140017817 @default.
- W2000685037 cites W2142149038 @default.
- W2000685037 cites W2161767400 @default.
- W2000685037 cites W2314878836 @default.
- W2000685037 cites W2560410594 @default.
- W2000685037 cites W2582322860 @default.
- W2000685037 cites W2587876253 @default.
- W2000685037 doi "https://doi.org/10.1016/j.critrevonc.2013.02.001" @default.
- W2000685037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23786844" @default.
- W2000685037 hasPublicationYear "2013" @default.
- W2000685037 type Work @default.
- W2000685037 sameAs 2000685037 @default.
- W2000685037 citedByCount "28" @default.
- W2000685037 countsByYear W20006850372013 @default.
- W2000685037 countsByYear W20006850372014 @default.
- W2000685037 countsByYear W20006850372015 @default.
- W2000685037 countsByYear W20006850372016 @default.
- W2000685037 countsByYear W20006850372017 @default.
- W2000685037 countsByYear W20006850372018 @default.
- W2000685037 countsByYear W20006850372019 @default.
- W2000685037 countsByYear W20006850372020 @default.
- W2000685037 countsByYear W20006850372022 @default.
- W2000685037 countsByYear W20006850372023 @default.
- W2000685037 crossrefType "journal-article" @default.
- W2000685037 hasAuthorship W2000685037A5043526996 @default.
- W2000685037 hasAuthorship W2000685037A5056839401 @default.
- W2000685037 hasAuthorship W2000685037A5076611748 @default.
- W2000685037 hasConcept C121332964 @default.
- W2000685037 hasConcept C126322002 @default.
- W2000685037 hasConcept C142424586 @default.
- W2000685037 hasConcept C143998085 @default.
- W2000685037 hasConcept C197934379 @default.
- W2000685037 hasConcept C2776063141 @default.
- W2000685037 hasConcept C2776364478 @default.
- W2000685037 hasConcept C2777478702 @default.
- W2000685037 hasConcept C2778524551 @default.
- W2000685037 hasConcept C2779609412 @default.
- W2000685037 hasConcept C2780401358 @default.
- W2000685037 hasConcept C2781413609 @default.
- W2000685037 hasConcept C31760486 @default.
- W2000685037 hasConcept C535046627 @default.
- W2000685037 hasConcept C71924100 @default.
- W2000685037 hasConcept C87355193 @default.
- W2000685037 hasConcept C98274493 @default.
- W2000685037 hasConceptScore W2000685037C121332964 @default.
- W2000685037 hasConceptScore W2000685037C126322002 @default.
- W2000685037 hasConceptScore W2000685037C142424586 @default.
- W2000685037 hasConceptScore W2000685037C143998085 @default.
- W2000685037 hasConceptScore W2000685037C197934379 @default.
- W2000685037 hasConceptScore W2000685037C2776063141 @default.
- W2000685037 hasConceptScore W2000685037C2776364478 @default.
- W2000685037 hasConceptScore W2000685037C2777478702 @default.
- W2000685037 hasConceptScore W2000685037C2778524551 @default.
- W2000685037 hasConceptScore W2000685037C2779609412 @default.
- W2000685037 hasConceptScore W2000685037C2780401358 @default.
- W2000685037 hasConceptScore W2000685037C2781413609 @default.
- W2000685037 hasConceptScore W2000685037C31760486 @default.
- W2000685037 hasConceptScore W2000685037C535046627 @default.
- W2000685037 hasConceptScore W2000685037C71924100 @default.